Scholarlink

Background <p>Alkali-induced ocular injury is a severe blinding disease where oxidative stress and ferroptosis drive corneal neovascularization and fibrosis. The natural compound sulforaphane (SFN) can inhibit these processes but its efficacy is limited by poor solubility, inadequate corneal penetration, and short ocular retention.</p> Methods <p>SFN-loaded liposomes (LPS) were prepared and incorporated into a poloxamer-based thermosensitive hydrogel (HP@LPS). Its gelation properties at ocular surface temperature and in vitro release were characterized. The antioxidant and anti-ferroptosis effects of LPS were evaluated in vitro, while therapeutic efficacy of HP@LPS in inhibiting neovascularization, fibrosis, and promoting corneal repair was assessed in a rat alkali burn model.</p> Results <p>HP@LPS was successfully developed, undergoing in situ gelation for sustained SFN release, with LPS ensuring efficient corneal penetration. In vitro, LPS attenuated oxidative stress and lipid peroxidation, upregulated ferroptosis-inhibitory proteins, and suppressed neovascularization and fibrosis. In vivo, HP@LPS ameliorated inflammation, neovascularization, and fibrosis through synergistic antioxidative and anti-ferroptotic mechanisms, with favorable bioavailability and minimal toxicity.</p> Conclusions <p>HP@LPS enhanced corneal retention and stromal penetration of SFN, promoting corneal repair and regeneration. This system offers a novel therapeutic strategy for corneal alkali burn and represents a promising candidate for clinical translation.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

An enhanced-permeability amphiphilic nanogel loaded with sulforaphane for synergistic anti-oxidative and anti-ferroptotic therapy of corneal alkali burn

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月14日

查看全文
  • Chengcheng Yang,
  • Yuxi Huang,
  • Yichi Zhang,
  • Yubo Zhang,
  • Wenting Luo,
  • Xiaomei Ke,
  • Songying Pi,
  • Hui Chen,
  • Shushan Zhang

摘要

Background

Alkali-induced ocular injury is a severe blinding disease where oxidative stress and ferroptosis drive corneal neovascularization and fibrosis. The natural compound sulforaphane (SFN) can inhibit these processes but its efficacy is limited by poor solubility, inadequate corneal penetration, and short ocular retention.

Methods

SFN-loaded liposomes (LPS) were prepared and incorporated into a poloxamer-based thermosensitive hydrogel (HP@LPS). Its gelation properties at ocular surface temperature and in vitro release were characterized. The antioxidant and anti-ferroptosis effects of LPS were evaluated in vitro, while therapeutic efficacy of HP@LPS in inhibiting neovascularization, fibrosis, and promoting corneal repair was assessed in a rat alkali burn model.

Results

HP@LPS was successfully developed, undergoing in situ gelation for sustained SFN release, with LPS ensuring efficient corneal penetration. In vitro, LPS attenuated oxidative stress and lipid peroxidation, upregulated ferroptosis-inhibitory proteins, and suppressed neovascularization and fibrosis. In vivo, HP@LPS ameliorated inflammation, neovascularization, and fibrosis through synergistic antioxidative and anti-ferroptotic mechanisms, with favorable bioavailability and minimal toxicity.

Conclusions

HP@LPS enhanced corneal retention and stromal penetration of SFN, promoting corneal repair and regeneration. This system offers a novel therapeutic strategy for corneal alkali burn and represents a promising candidate for clinical translation.

Graphical Abstract